REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Debt to Equity Ratio : 3.49 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.49 |
| March 31, 2026 | 11.78 |
| December 31, 2025 | 2.536 |
| September 30, 2025 | 1.661 |
| June 30, 2025 | 1.272 |
| March 31, 2025 | 0.487 |
| December 31, 2024 | 0.5458 |
| September 30, 2024 | 0.4838 |
| June 30, 2024 | 0.4557 |
| March 31, 2024 | 0.4366 |
| December 31, 2023 | 0.2864 |
| September 30, 2023 | 0.2498 |
| June 30, 2023 | 0.2256 |
| March 31, 2023 | 0.2006 |
| December 31, 2022 | 0.1836 |
| September 30, 2022 | 0.1566 |
| June 30, 2022 | 0.1404 |
| March 31, 2022 | 0.1271 |
| December 31, 2021 | 0.1134 |
| September 30, 2021 | 0.1847 |
| June 30, 2021 | 0.1658 |
| March 31, 2021 | 0.1387 |
| December 31, 2020 | 0.1923 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1468 |
| June 30, 2020 | 0.0254 |
| March 31, 2020 | 0.0249 |
| December 31, 2019 | 0.0251 |
| September 30, 2019 | 0.0146 |
| June 30, 2019 | 0.014 |
| March 31, 2019 | 0.0162 |
| December 31, 2018 | 0.0115 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Capricor Therapeutics, Inc. | 0.3698 |
| Biogen, Inc. | 0.4433 |
| Ardelyx, Inc. | 1.719 |
| Ocugen, Inc. | -5.314 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 386.62M |
| Total Liabilities (Quarterly) | 314.85M |
| Shareholders Equity (Quarterly) | 71.76M |
| Current Ratio | 2.858 |
| Net Debt Paydown Yield | -3.60% |